Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT04162769

Public ClinicalTrials.gov record NCT04162769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 8:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled 16-Week Study (With a 52-Week Open-Label Extension) to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether etrasimod is a safe and effective treatment for moderate-to-severe atopic dermatitis (AD).

Study identification

NCT ID
NCT04162769
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Arena Pharmaceuticals
Industry
Enrollment
140 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 4, 2019 (Actual)
Primary completion
Sep 9, 2020 (Actual)
Completion
Oct 11, 2021 (Actual)
Last update posted
Nov 4, 2022

2019 – 2021

United States locations

U.S. sites
35
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Noble Clinical Research Tucson Arizona 85704 —
Hope Clinical Research Canoga Park California 91303 —
First OC Dermatology Fountain Valley California 92708 —
Marvel Research LLC Huntington Beach California 92647 —
ADVA Clinical Research, Inc Inglewood California 90301 —
Providence Clinical Research North Hollywood California 91606 —
TCR Medical Corporation San Diego California 92123 —
Clinical Research of West Florida Clearwater Florida 33765 —
Prohealth Research Center Doral Florida 33166 —
Aby's New Generation Research, Inc. Hialeah Florida 33016 —
Skin Care Research, LLC Hollywood Florida 33021 —
Advanced Research Institute of Miami LLC Homestead Florida 33030 —
Amber Pediatrics Research, LLC Homestead Florida 33030 —
South Miami Medical & Research Group. Inc Miami Florida 33155 —
Amber Pediatrics Research, LLC Miami Florida 33169 —
Skin Research of South Florida Miami Florida 33173 —
Amber Clinical Research, LLC Miami Shores Florida 33138 —
IMA Clinical Research, LLC St. Petersburg Florida 33709 —
Clinical Research of West Florida, Inc. Tampa Florida 33603 —
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291 —
Skin Sciences PLLC Louisville Kentucky 40217 —
Quinn Healthcare/SKYCRNG Ridgeland Mississippi 39157 —
Quality Clinical Research Inc Omaha Nebraska 68114 —
Excel Clinical Research Las Vegas Nevada 89109 —
Greenwich Village Dermatology New York New York 10012 —
ODRC Enterprises, LLC dba Oregon Dermatology and Research Center Portland Oregon 97210 —
Spartanburg Medical Research Spartanburg South Carolina 29369 —
Health Concepts Rapid City South Dakota 57702 —
Gadolin Research Beaumont Texas 77702 —
Modern Research Associates, PLLC Dallas Texas 75231 —
FMC Science Georgetown Texas 78626 —
FMC Science Lampasas Texas 76550 —
Alliance for Multispecialty Research Norfolk Virginia 23507 —
Clinical Research Partners, LLC Richmond Virginia 23220 —
Premier Clinical Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04162769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2022 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04162769 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →